These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
92 related items for PubMed ID: 22047692
21. Potent, orally bioavailable, liver-selective stearoyl-CoA desaturase (SCD) inhibitors. Koltun DO, Zilbershtein TM, Migulin VA, Vasilevich NI, Parkhill EQ, Glushkov AI, McGregor MJ, Brunn SA, Chu N, Hao J, Mollova N, Leung K, Chisholm JW, Zablocki J. Bioorg Med Chem Lett; 2009 Aug 01; 19(15):4070-4. PubMed ID: 19577469 [Abstract] [Full Text] [Related]
22. Discovery of Novel and Potent Stearoyl Coenzyme A Desaturase 1 (SCD1) Inhibitors as Anticancer Agents. Imamura K, Tomita N, Kawakita Y, Ito Y, Ono K, Nii N, Miyazaki T, Yonemori K, Tawada M, Sumi H, Satoh Y, Yamamoto Y, Miyahisa I, Sasaki M, Satomi Y, Hirayama M, Nishigaki R, Maezaki H. Bioorg Med Chem; 2017 Jul 15; 25(14):3768-3779. PubMed ID: 28571972 [Abstract] [Full Text] [Related]
23. Novel and potent inhibitors of stearoyl-CoA desaturase-1. Part II: Identification of 4-ethylamino-3-(2-hydroxyethoxy)-N-[5-(3-trifluoromethylbenzyl)thiazol-2-yl]benzamide and its biological evaluation. Uto Y, Ogata T, Kiyotsuka Y, Miyazawa Y, Ueno Y, Kurata H, Deguchi T, Yamada M, Watanabe N, Takagi T, Wakimoto S, Okuyama R, Konishi M, Kurikawa N, Kono K, Osumi J. Bioorg Med Chem Lett; 2009 Aug 01; 19(15):4159-66. PubMed ID: 19541482 [Abstract] [Full Text] [Related]
24. Development of a novel LC/MS method to quantitate cellular stearoyl-CoA desaturase activity. Dillon R, Greig MJ, Bhat BG. Anal Chim Acta; 2008 Oct 03; 627(1):99-104. PubMed ID: 18790132 [Abstract] [Full Text] [Related]
25. Novel substituted heteroaromatic compounds as inhibitors of stearoyl-CoA desaturase. Dobrzyn P, Dobrzyn A. Expert Opin Ther Pat; 2010 Jun 03; 20(6):849-53. PubMed ID: 20205608 [Abstract] [Full Text] [Related]
26. Discovery of novel SCD1 inhibitors: 5-alkyl-4,5-dihydro-3H-spiro[1,5-benzoxazepine-2,4'-piperidine] analogs. Uto Y, Ueno Y, Kiyotsuka Y, Miyazawa Y, Kurata H, Ogata T, Takagi T, Wakimoto S, Ohsumi J. Eur J Med Chem; 2011 May 03; 46(5):1892-6. PubMed ID: 21356569 [Abstract] [Full Text] [Related]
28. Benzimidazole-carboxamides as potent and bioavailable stearoyl-CoA desaturase (SCD1) inhibitors from ligand-based virtual screening and chemical optimization. Matter H, Zoller G, Herling AW, Sanchez-Arias JA, Philippo C, Namane C, Kohlmann M, Pfenninger A, Voss MD. Bioorg Med Chem Lett; 2013 Mar 15; 23(6):1817-22. PubMed ID: 23395660 [Abstract] [Full Text] [Related]
29. 4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable stearoyl-CoA desaturase-1 (SCD1) inhibitors: part 2. Pyridazine-based analogs. Yang SM, Tang Y, Rano T, Lu H, Kuo GH, Gaul MD, Li Y, Ho G, Lang W, Conway JG, Liang Y, Lenhard JM, Demarest KT, Murray WV. Bioorg Med Chem Lett; 2014 Mar 01; 24(5):1437-41. PubMed ID: 24405703 [Abstract] [Full Text] [Related]
30. Novel spiropiperidine-based stearoyl-CoA desaturase-1 inhibitors: Identification of 1'-{6-[5-(pyridin-3-ylmethyl)-1,3,4-oxadiazol-2-yl]pyridazin-3-yl}-5-(trifluoromethyl)-3,4-dihydrospiro[chromene-2,4'-piperidine]. Uto Y, Kiyotsuka Y, Ueno Y, Miyazawa Y, Kurata H, Ogata T, Deguchi T, Yamada M, Watanabe N, Konishi M, Kurikawa N, Takagi T, Wakimoto S, Kono K, Ohsumi J. Bioorg Med Chem Lett; 2010 Jan 15; 20(2):746-54. PubMed ID: 20006498 [Abstract] [Full Text] [Related]